Feb 06, 2020
AFTD Welcomes Rosa Canet-Avilés, Ph.D., as Senior Director of Scientific Initiatives
Feb 04, 2020
Study Published in Nature Communications Highlights the Role of the Epichaperome in Protein Connectivity-based Dysfunction in Alzheimer's Disease
Jan 27, 2020
Pacific Neuroscience Institute Offers Final Enrollment into Important Clinical Trial for Patients with Lewy Body Dementia
Jan 13, 2020
Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights
Dec 17, 2019
BioArctic Announces Research Collaboration with Eisai Regarding BAN2401
Dec 16, 2019
Alzheimer's Association Launches New Health Systems Initiative
Dec 10, 2019
St. Croix Hospice launches North Star Dementia Program
Dec 10, 2019
Eisai Presents New Analyses of Potential Blood-Based Alzheimer's Diagnostic Test and Lemborexant as Potential Sleep-Wake Disorder Therapy
Dec 06, 2019
Biohaven's Troriluzole Successfully Advances Past Interim Futility Analysis In Pivotal Phase 2/3 Alzheimer's Disease Study
Dec 05, 2019
BioArctic's Partner Eisai Presents Data from the Ongoing BAN2401 Phase 2b Extension Study in Early Alzheimer's Disease
Dec 05, 2019
EIP Pharma Announces Presentation of Phase 2b Clinical Trial Results of Neflamapimod in Early-stage Alzheimer's Disease at Clinical Trials in Alzheimer's Disease (CTAD) meeting
Dec 04, 2019
Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator Announces Second Round of Awards
Dec 04, 2019
Developing Dementia Diagnostic Test Domestically in Japan with Retinal Imaging AI - Partnership Concluded with Canadian Optina Diagnostics to Build a Business in the Japanese Market
Dec 02, 2019
Eisai and Biogen's Joint Investigational Asset BAN2401 Data to be Presented at Clinical Trials on Alzheimer's Disease Conference
Dec 02, 2019
BioArctic and Eisai to Present Data on BAN2401 at the Clinical Trials on Alzheimer's Disease Conference
Nov 26, 2019
New Study by TauRx Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer's Disease
Nov 21, 2019
Major Research Funding for Blood Test to Accelerate Clinical Trials for New Frontotemporal Degeneration (FTD) Therapies
Nov 20, 2019
New Research Demonstrates Second Direct Link Between Inflammasome Activation and Alzheimer's Disease
Nov 18, 2019
Alkermes to Acquire Rodin Therapeutics
Nov 13, 2019
Alzheimer's Association Receives $1.34 Million NIH Grant to Enhance Psychosocial Research for Dementia Care